Camp4 Therapeutics Corp (CAMP)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, Camp4 Therapeutics Corp reported revenue of $3.50M, up 436.5% from the prior year. The company ran a net loss, with a net margin of -2298.5%. It held $117.81M in total assets against $70.10M in total liabilities.
Key ratios (FY2025)
-1502.4%
Operating margin
-2298.5%
Net margin
-168.5%
Return on equity
+436.5%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $3.50M | $652.0K | $350.0K | — |
| Operating Income | -$52.55M | -$53.09M | -$51.88M | — |
| Net Income | -$80.40M | -$51.79M | -$49.29M | — |
| EPS (Diluted) | $-2.65 | $-11.04 | $-124.80 | — |
| Total Assets | $117.81M | $78.31M | $54.95M | — |
| Total Liabilities | $70.10M | $15.16M | $16.53M | — |
| Shareholders' Equity | $47.70M | $63.14M | -$123.73M | -$77.53M |
| Cash & Equivalents | $109.52M | $64.04M | $38.38M | — |
| Operating Cash Flow | -$29.55M | -$45.56M | -$44.16M | — |
| Capital Expenditures | $279.0K | $441.0K | $678.0K | — |
| Shares Outstanding | 51.90M | 20.15M | 460.7K | — |
| Dividends Per Share | $0.00 | $0.00 | — | — |